![Rogério Vivaldi Coelho](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rogério Vivaldi Coelho
Directeur/Bestuurslid bij
CRINETICS PHARMACEUTICALS, INC.
Vermogen: 2 M $ op 31-07-2026
Profiel
Rogério Vivaldi Coelho was the founder of Minerva Neurosciences, Inc., founded in 2007, where the title held was President, Chief Executive Officer & Director in 2014.
Current jobs include Independent Director at Crinetics Pharmaceuticals, Inc. since 2022 and Independent Director at Viatris, Inc. since 2024.
Former jobs include President, Chief Executive Officer & Director at Sigilon Therapeutics, Inc. from 2022 to 2023; Director at Mind-NRG SARL in 2014; President-Rare Disease, Renal & Endocrine, SVP at Genzyme Corp.
from 1997 to 2014; Chief Commercial Officer at Spark Therapeutics, Inc. from 2015 to 2016; and Chief Global Therapeutics Officer & Executive VP at Bioverativ, Inc. from 2016 to 2018.
Education includes a doctorate from the Federal University of Rio de Janeiro and an MBA from COPPEAD Graduate School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 08-07-2026 | 13.300 ( 0,01% ) | 1 M $ | 31-07-2026 | |
| 26-03-2026 | 46.526 ( 0% ) | 816 997 $ | 31-07-2026 |
Actieve functies van Rogério Vivaldi Coelho
| Bedrijven | Functie | Begin |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 03-01-2022 |
| VIATRIS INC. | Directeur/Bestuurslid | 03-06-2024 |
Eerdere bekende functies van Rogério Vivaldi Coelho
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOVERATIV INC | Corporate Officer/Principal | 01-01-2018 |
| SPARK THERAPEUTICS, INC. | Directeur/Bestuurslid | 05-01-2015 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| MINERVA NEUROSCIENCES, INC. | Oprichter | 20-11-2014 |
Mind-NRG SARL
 Mind-NRG SARL Medical/Nursing ServicesHealth Services Provides research and drug development services | Directeur/Bestuurslid | 20-11-2014 |
Opleiding van Rogério Vivaldi Coelho
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
96
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Federal University of Rio de Janeiro
 Federal University of Rio de Janeiro Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mind-NRG SARL
Mind-NRG SARL Medical/Nursing ServicesHealth Services Provides research and drug development services | Health Services |
COPPEAD Graduate School of Business
 COPPEAD Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Minerva Neurosciences, Inc.
 Minerva Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes drugs to treat patients suffering from central nervous system diseases | Health Technology |
Crinetics Pharmaceuticals, Inc.
 Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
Viatris, Inc.
 Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
